清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 Study

多发性骨髓瘤 肾功能 医学 移植 内科学 肿瘤科 肌酐 自体干细胞移植 泌尿科
作者
Yaeni Kim,Sung‐Soo Park,Young‐Woo Jeon,Seung‐Ah Yahng,Seung-Hwan Shin,Chang‐Ki Min
出处
期刊: [Elsevier BV]
卷期号:29 (1): 55.e1-55.e9 被引量:2
标识
DOI:10.1016/j.jtct.2022.09.024
摘要

Newly diagnosed multiple myeloma (NDMM) frequently results in renal impairment (RI), and its natural course has not been fully elucidated in the era of novel agents. We aimed to identify the dynamics of renal function after autologous stem cell transplantation (ASCT) following induction treatment using a novel agent in transplantation-eligible NDMM patients with RI (estimated glomerular filtration rate [eGFR] ≤50 mL/min/1.73 m2) at diagnosis. The factors associated with achieving a renal response based on the term renal benefit regardless of baseline eGFR were investigated as well. In a multicenter registry database including 1795 patients with plasma cell disorder, 140 transplantation-eligible NDMM patients who developed RI at the time of initiation of treatment for NDMM were identified. They received protocol-based treatment (PBT) consisting of induction treatment using proteasome inhibitors and/or immunomodulatory drugs followed by ASCT. MM and renal responses were evaluated using the International Myeloma Working Group response criteria. To evaluate the standardized improvement of renal function irrespective of baseline eGFR, renal benefit was defined as a sustained (for at least 3 months) increase in eGFR >15 mL/min/1.73 m2. The mean patient age was 54.7 ± 7.4 years. With a mean baseline eGFR of 24.8 ± 13.9, the renal complete response (renalCR) and renal benefit rates were 49.3% and 67.9%, respectively. In a multivariable analysis, the 3 factors significantly associated with reduced likelihood of achieving both renalCR and renal benefit were age ≥55 years, light chain type NDMM, and failure to improve eGFR by 5 mL/min/1.73 m2 with supportive care when measured 3 days prior to induction therapy and at the initiation of chemotherapy. Hypertension and advanced eGFR also were associated with poor renalCR achievement. The mean eGFR improved until the time of ASCT and then decreased gradually over time. The mean eGFR improved significantly until 4 months post-PBT compared with each eGFR at previous time points, but this significant improvement disappeared by 5 months post-PBT. In a subgroup of patients who developed RI after undergoing ASCT (n = 55), the eGFR increased temporarily at 1 month post-ASCT; however, this improvement reverted to baseline at 2 months post-ASCT. Among another subgroup of 27 patients who were dialysis-dependent at the time of initial treatment, 18 (66.7%) were no longer dialysis-dependent after a median of 60 days. The best renal response was acquired early during the PBT period, and ASCT did not have a robust impact on the renal outcome. Patients who failed to achieve a renal benefit should be provided with the best supportive care for chronic kidney disease, and this simplified criterion for evaluating the renal response needs to be validated in larger studies before it can be recommended. © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
flb1227完成签到 ,获得积分10
1秒前
纤花语完成签到 ,获得积分10
2秒前
英俊的谷蓝完成签到,获得积分10
7秒前
eric_dai完成签到,获得积分10
9秒前
可靠纸飞机完成签到,获得积分10
17秒前
无辜的若枫完成签到 ,获得积分10
17秒前
21秒前
可靠的志泽完成签到 ,获得积分10
32秒前
jlwang完成签到,获得积分10
35秒前
谦让康完成签到 ,获得积分10
36秒前
文静的丹彤完成签到,获得积分10
44秒前
安静惋清完成签到,获得积分10
46秒前
eric_dai发布了新的文献求助20
55秒前
和谐的小懒虫完成签到,获得积分10
1分钟前
粗暴的镜子完成签到,获得积分10
1分钟前
开放的蚂蚁完成签到,获得积分10
1分钟前
17991完成签到,获得积分10
1分钟前
调皮烤鸡完成签到,获得积分10
1分钟前
苗苗完成签到,获得积分10
1分钟前
lishuhua完成签到 ,获得积分10
1分钟前
berry完成签到,获得积分10
1分钟前
Jasonkun完成签到,获得积分10
1分钟前
linj完成签到,获得积分10
1分钟前
虚幻百招完成签到,获得积分10
1分钟前
whitepiece完成签到,获得积分0
1分钟前
开放的乐驹完成签到 ,获得积分10
1分钟前
畅快天空完成签到,获得积分10
1分钟前
怕黑的店员完成签到,获得积分10
1分钟前
muriel完成签到,获得积分0
2分钟前
creep2020完成签到,获得积分0
2分钟前
高贵的晓啸完成签到,获得积分10
2分钟前
jlin完成签到,获得积分10
2分钟前
铜豌豆完成签到 ,获得积分10
2分钟前
冷静的尔竹完成签到,获得积分10
2分钟前
无情幻巧完成签到,获得积分10
2分钟前
珈沐完成签到,获得积分10
2分钟前
今后的应助被gyc采纳,获得10
2分钟前
e746700020完成签到,获得积分10
2分钟前
简单完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166425
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750507
捐赠科研通 7757226
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553507
邀请新用户注册赠送积分活动 2473845